Infants’ Immune Response to Severe COVID-19

Infants hospitalized with severe COVID-19 exhibit an immune response that differs markedly from older children and adults. Researchers discovered elevated levels of both interferon responses and inflammation occurring simultaneously, a phenomenon not previously noted in other viral infections.

The study revealed that T and B cells in these infants, while still naïve, showed significant activation. Some even produced their own strong antibody responses, which was unexpected considering their young age. This indicates that the immune systems of infants function according to different principles, suggesting that tailored treatment and prevention strategies are necessary.

Key Findings

• Dual Activation: Infants showed unusual simultaneous high interferon levels alongside inflammation.
• Naïve but Active: Infants’ T and B cells were highly activated despite lacking prior exposure to infection.
• Independent Antibodies: Some infants generated strong antibodies against SARS-CoV-2, even while dependent on maternal immunity.

The research was a collaborative effort from several institutions, including St. Jude Children’s Research Hospital, Weill Cornell Medicine, and others. Researchers examined the immune cells of infants from a few weeks to 16 months and compared them to those of healthy infants and adults with COVID-19.

While monocytes from hospitalized infants shared some similarities with those in infected adults, T and B cells showed notable differences. Hospitalized infants had an increased number of CD4 T cells, and these cells expressed antiviral interferon responses, resulting in a higher expression of interferon-stimulated genes than seen in older age groups.

Conflicting Signals from Infant Immune Systems

Most immune cells in infants revealed high interferon-stimulated gene expression. Surprisingly, tests showed high levels of inflammation-inducing molecules as well. This diverges from earlier observations in infants with milder infections.

These findings challenge conventional views about how infant immune systems respond to SARS-CoV-2. “Typically, we expect the systems regulating interferon and inflammation to counterbalance each other,” noted one of the study’s authors. However, this research shows both systems can be upregulated simultaneously in infants, a departure from what has been observed in other respiratory viruses.

By using single-cell RNA sequencing, researchers could identify the unique immune features in infants and relate them to the severity of their illness. More severe cases were correlated with higher levels of both interferon and inflammatory cytokines, raising questions about their roles in protection versus contribution to severe disease.

Understanding Infant Antibody Responses

B cells are crucial for producing antibodies that fight off viruses. Typically, infants depend on maternal antibodies until about six months of age. During the pandemic, the researchers investigated whether maternal immunity to common cold coronaviruses could provide some protection to infants.

Surprisingly, it was found that many infants generated strong new antibody responses to SARS-CoV-2, even those only a few weeks old. The pre-existing maternal antibodies did not seem to help prevent infections. Furthermore, the lack of anti-interferon antibodies associated with severe COVID-19 in adults indicates that the immune mechanisms in infants differ significantly.

“We’ve shown that infants respond to SARS-CoV-2, but in a distinctive manner,” remarked a co-author. “As COVID-19 evolves into an endemic virus, gaining a better understanding of infant immune responses is essential for developing effective protective measures.”